News Home

Analyst Rating: Will Sesen Bio Inc (SESN) Stock Do Better Than the Market?

Monday, October 18, 2021 02:10 PM | InvestorsObserver Analysts
Analyst Rating: Will Sesen Bio Inc (SESN) Stock Do Better Than the Market?

Wall Street is positive on Sesen Bio Inc (SESN). On average, analysts give SESN a Buy rating. The average price target is $4.25, which means analysts expect the stock to gain by 356.99% over the next twelve months. That average ranking earns SESN an Analyst Rating of 20, which is better than 20% of stocks based on data compiled by InvestorsObserver.

Overall Score - 3.7
Wall Street analysts are rating SESN a Buy today. Find out what this means to you and get the rest of the rankings on SESN!

Why are Analyst Ratings Important?

A company's financial statements are a significant factor weighted by experts when analyzing a company's health. Beyond just the numbers, analysts follow specific industries closely and are able to gain a detailed understanding of how a storm in one part of the world can shutdown supply chains leading to a change in consumption across the globe. This knowledge allows investors to respond to potential changes in the market before they are revealed in a quarterly annoucement. InvestorsObserver averages the ratings across all these analysts and percentile ranks those averages. This allows you to compare stocks in greater detail than the usual five-tiered system used amongst the majority of investors.

What's Happening With Sesen Bio Inc Stock Today?

Sesen Bio Inc (SESN) stock is lower by -3.36% while the S&P 500 is higher by 0.19% as of 2:09 PM on Monday, Oct 18. SESN is down -$0.03 from the previous closing price of $0.96 on volume of 5,455,579 shares. Over the past year the S&P 500 is up 30.72% while SESN is down -16.96%. SESN lost -$0.80 per share the over the last 12 months. Click Here to get the full Stock Report for Sesen Bio Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App